Research Presentation Sessions: Genitourinary

RPS 2307 - Prostate cancer: detection, surveillance and relapse

Lectures

1
Accuracy of magnetic resonance imaging-ultrasound fusion-guided and systematic biopsy of the prostate

Accuracy of magnetic resonance imaging-ultrasound fusion-guided and systematic biopsy of the prostate

07:00Thomas in de Braekt, Eindhoven / NL

2
Role of the PI-QUAL score for prostate MRI quality in the detection of clinically significant cancer in equivocal lesions

Role of the PI-QUAL score for prostate MRI quality in the detection of clinically significant cancer in equivocal lesions

07:00Alexandre Edward Woernle, London / UK

3
Inter-reader variability of manual segmentation of prostate volume on T2-weighted MRI: what an impact on PSA density?

Inter-reader variability of manual segmentation of prostate volume on T2-weighted MRI: what an impact on PSA density?

07:00Anna Colarieti, Milan / IT

4
Diagnostic accuracy of PI-RADS 4 upgraded from PI-RADS 3 as a consequence of positive DCE MRI in prostate peripheral zone lesions. Towards two new subgroups: PI-RADS 3F and PI-RADS 3B

Diagnostic accuracy of PI-RADS 4 upgraded from PI-RADS 3 as a consequence of positive DCE MRI in prostate peripheral zone lesions. Towards two new subgroups: PI-RADS 3F and PI-RADS 3B

07:00Martina Pecoraro, Rome / IT

5
Improved diffusion-weighted imaging of the prostate: comparison of readout-segmented and zoomed single-shot imaging

Improved diffusion-weighted imaging of the prostate: comparison of readout-segmented and zoomed single-shot imaging

07:00Matthias Boschheidgen, Düsseldorf / DE

6
Predicting factors for extraprostatic extension in patients with prostate cancer using decision curve analysis

Predicting factors for extraprostatic extension in patients with prostate cancer using decision curve analysis

07:00HYUN MIN KIM, Daegu / KR

7
Prediction of extraprostatic extension with TCL measurement: role of the zonal level of prostate cancer

Prediction of extraprostatic extension with TCL measurement: role of the zonal level of prostate cancer

07:00Seo Young Park, Daegu / KR

8
High-performance integrative mathematical models for pathological status prediction in a large series of PCa patients: added value of radiomics and mp-MRI

High-performance integrative mathematical models for pathological status prediction in a large series of PCa patients: added value of radiomics and mp-MRI

07:00Federico Mastroleo, Milan / IT

9
Predictive role of Node-RADS in patients with PCa candidates for radical prostatectomy with extended lymph node dissection: a comparative analysis with validated nomograms

Predictive role of Node-RADS in patients with PCa candidates for radical prostatectomy with extended lymph node dissection: a comparative analysis with validated nomograms

07:00Ludovica Laschena, Rome / IT

10
Clinical application of the PRECISE score for reporting magnetic resonance imaging in men on active surveillance for prostate cancer

Clinical application of the PRECISE score for reporting magnetic resonance imaging in men on active surveillance for prostate cancer

07:00Pieter Julien Luc De Visschere, Ghent / BE

11
Prostate imaging for recurrence reporting (PI-RR) assessment score: diagnostic accuracy, interobserver agreement among readers with variable experience, and correlation with PSA levels

Prostate imaging for recurrence reporting (PI-RR) assessment score: diagnostic accuracy, interobserver agreement among readers with variable experience, and correlation with PSA levels

07:00Paolo Niccolò Franco, Monza / IT

12
Apparent diffusion coefficient for the prediction of biochemical recurrence after prostatectomy in patients with prostate cancer

Apparent diffusion coefficient for the prediction of biochemical recurrence after prostatectomy in patients with prostate cancer

07:00Roberta Maggioni, Veduggio Con Colzano / IT

13
Moderation

Moderation

00:00Tristan Barrett, Cambridge / UK

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.